New China Life Insurance (01336) Releases Q3 2025 Financial Results: Net Profit Up 58.9%, Solid Business Growth

Bulletin Express
Yesterday

New China Life Insurance Company Ltd. (01336) disclosed its unaudited third-quarter 2025 financial results, highlighting a 28.3% year-on-year increase in operating income to RMB137,252 million. Net profit attributable to shareholders reached RMB32,857 million, marking a 58.9% rise. The weighted average return on equity climbed to 33.1%, up 12.1 percentage points compared to the same period in 2024. Total assets stood at RMB1,833,491 million, indicating an 8.3% increase from the end of 2024.

Gross written premiums for the first three quarters totaled RMB172,705 million, up 18.6% year-on-year. First year premiums for long-term insurance business rose 59.8% to RMB54,569 million, while renewal premiums grew 5.9% to RMB114,620 million. The surrender rate declined to 1.2%, and the value of new business expanded by 50.8%. The overall performance benefited from steady progress in key distribution channels, with the bancassurance segment achieving a notable 66.7% jump in first year long-term insurance premiums.

In asset management, the company’s investment assets reached RMB1,770,185 million as of the end of September 2025. The annualized total investment yield stood at 8.6%, while the annualized comprehensive investment yield was 6.7%. The comprehensive solvency margin ratio came in at 234.15%. The company attributed its strong results, in part, to favorable capital market conditions observed through the first three quarters of 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10